AMRN Amarin Corp Plc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRN

Price (delayed)

$1.83

Market cap

$726.52M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$513.85M

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its ...

Highlights
AMRN's quick ratio is down by 23% year-on-year and by 5% since the previous quarter
AMRN's debt is up by 21% since the previous quarter and by 15% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.amarincorp.com
Peers: ABBV ALKS TEVA

Key stats

What are the main financial stats of AMRN
Market
Shares outstanding
397.01M
Market cap
$726.52M
Enterprise value
$513.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.13
Price to sales (P/S)
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.96
Earnings
Revenue
$535.65M
EBIT
-$15.66M
EBITDA
-$12.53M
Free cash flow
-$146.68M
Per share
EPS
-$0.05
Free cash flow per share
-$0.37
Book value per share
$1.62
Revenue per share
$1.35
TBVPS
$2.39
Balance sheet
Total assets
$973.71M
Total liabilities
$332.6M
Debt
$10.4M
Equity
$641.11M
Working capital
$472.05M
Liquidity
Debt to equity
0.02
Current ratio
2.57
Quick ratio
1.59
Net debt/EBITDA
16.97
Margins
EBITDA margin
-2.3%
Gross margin
78.5%
Net margin
-4.1%
Operating margin
-3.1%
Efficiency
Return on assets
-2.2%
Return on equity
-3.4%
Return on invested capital
-3.8%
Return on capital employed
-2.3%
Return on sales
-2.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMRN stock price

How has the Amarin stock price performed over time
Intraday
-1.08%
1 week
-2.66%
1 month
27.08%
1 year
-59.15%
YTD
-45.7%
QTD
-44.38%

Financial performance

How have Amarin's revenue and profit performed over time
Revenue
$535.65M
Gross profit
$420.41M
Operating income
-$16.47M
Net income
-$22.21M
Gross margin
78.5%
Net margin
-4.1%
Amarin's gross profit has decreased by 12% YoY and by 9% QoQ
The revenue is down by 11% year-on-year and by 8% since the previous quarter

Growth

What is Amarin's growth rate over time

Valuation

What is Amarin stock price valuation
P/E
N/A
P/B
1.13
P/S
1.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.96
AMRN's P/B is 54% below its last 4 quarters average of 2.5
The equity has declined by 3.9% since the previous quarter
The P/S is 84% less than the 5-year quarterly average of 8.8 and 49% less than the last 4 quarters average of 2.7
The revenue is down by 11% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Amarin business performance

Dividends

What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRN.

Financial health

How did Amarin financials performed over time
AMRN's total assets is 193% greater than its total liabilities
AMRN's quick ratio is down by 23% year-on-year and by 5% since the previous quarter
AMRN's total liabilities is down by 17% since the previous quarter and by 6% year-on-year
AMRN's debt is 98% smaller than its equity
Amarin's debt to equity has soared by 100% from the previous quarter and by 100% YoY
AMRN's debt is up by 21% since the previous quarter and by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.